Avidity Biosciences (RNA) Leases (2020 - 2025)
Historic Leases for Avidity Biosciences (RNA) over the last 6 years, with Q3 2025 value amounting to $52.8 million.
- Avidity Biosciences' Leases rose 73899.03% to $52.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.8 million, marking a year-over-year increase of 73899.03%. This contributed to the annual value of $5.6 million for FY2024, which is 3206.38% down from last year.
- Latest data reveals that Avidity Biosciences reported Leases of $52.8 million as of Q3 2025, which was up 73899.03% from $4.2 million recorded in Q2 2025.
- In the past 5 years, Avidity Biosciences' Leases registered a high of $52.8 million during Q3 2025, and its lowest value of $45000.0 during Q3 2021.
- Its 5-year average for Leases is $9.0 million, with a median of $7.8 million in 2023.
- In the last 5 years, Avidity Biosciences' Leases plummeted by 8793.57% in 2021 and then surged by 2048666.67% in 2022.
- Quarter analysis of 5 years shows Avidity Biosciences' Leases stood at $10.8 million in 2021, then fell by 18.81% to $8.8 million in 2022, then decreased by 5.53% to $8.3 million in 2023, then tumbled by 32.06% to $5.6 million in 2024, then surged by 840.52% to $52.8 million in 2025.
- Its Leases was $52.8 million in Q3 2025, compared to $4.2 million in Q2 2025 and $4.9 million in Q1 2025.